177Lu-tetraxetan-tetulomab

[email protected]
177Lu-tetraxetan-tetulomab
Trade Name Betalutin
Orphan Indication Follicular lymphoma
USA Market Approval USA
USA Designation Date 2014-05-14 00:00:00
Sponsor Nordic Nanovector AS;Anniken Hagen, Kjelsasveien 168B, NO-0884;Oslo
Related Access Program
Kite, A Gilead Company – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Transformed Follicular Lymphoma